We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA’s Science Board Reviews Agency’s $500 Million Cures Act Work Plan
FDA’s Science Board Reviews Agency’s $500 Million Cures Act Work Plan
In a Tuesday meeting, the FDA’s Science Board reviewed and largely supported the agency’s proposed plan for implementing the 21st Century Cures Act over the next nine years.